ArticleFrontiers in medicine2025
Pulmonary MALT lymphoma diagnosed with transbronchial lung cryobiopsy after unsuccessful transbronchial lung biopsy: a case report.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma is a rare primary lung neoplasm and a low-grade B-cell non-Hodgkin lymphoma subtype. Although the prognosis is generally favorable, nonsurgical biopsy methods often have a low diagnostic yield, leaving the optimal approach for pulmonary lesion biopsy unclear. This case study illustrates the successful diagnosis of pulmonary MALT lymphoma using transbronchial lung cryobiopsy (TBLC) after usual transbronchial lung biopsy (TBLB) failed to provide a definitive diagnosis. A 47-year-old female with no significant medical history was referred to our institution after a chest radiograph revealed abnormalities. Subsequent chest computed tomography showed tumorous lesions measuring 20 mm in the right middle lobe and 35 mm in the left lower lobe, prompting a bronchoscopic examination. Guided sheath transbronchial lung biopsy (GS-TBLB) was performed on these two lesions, revealing CD20-positive lymphocytic infiltration. However, the lack of a clear light chain restriction and minimal plasma cell differentiation did not suggest malignant lymphoma. Considering cryptogenic organizing pneumonia, prednisolone was administered for 3 months, but no changes in radiographic findings were observed. Therefore, a second bronchoscopic examination using TBLC was planned. TBLC was performed twice on the left lower lobe lesion, revealing diffuse infiltration of small lymphoid cells into the lung parenchyma and subepithelial bronchial tissue, with some cells differentiating into plasma cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.